Established in 2004, CIDP (Centre International de Développement Pharmaceutique) is an international Contract Research Organisation (CRO) that carries out high R&D activities for pharmaceutical, medical device, nutraceutical and cosmetic industries.
Check our latest publication demonstrating the efficacy of Mineral 89 Probiotic Fractions® (M89PF), developed to fulfil the need for adjunctive products that can reinforce skin barrier and manage retinoid induced irritation. The study demonstrated that the M89PF improved cutaneous irritation and significantly enhanced skin hydration, erythema, fine lines, skin tone, radiance and pore appearance.
Congratulations to all authors for this achievement. Camila Valpaços, Diego Svoboda, Dr Veronique NEWTON, Madiiha Mandary
Thank you, Dr Stéphanie LECLERC-MERCIER and team, for your trust.
Interested to learn more about our catalogue of studies and medical writing services, contact us on info@cidp-cro.com!
